PTPN11 and ovarian cancer: Gab2 can recruit Shp2 to activate Ras/ERK signaling in breast cancer and melanoma (43, 44), and the PI3K/Akt signaling pathway has been reported to be modulated by Gab2 in breast cancer (45), ovarian cancer (30, 37), and melanoma (46).